Why Immunovant, Inc. (IMVT) stock moved
Immunovant, Inc. (IMVT) shares tumbled 6.0% to $41.20 as of August 29, 2026, a significant decline from the prior close of $43.82. BestStocks flagged the session as a major change for IMVT. The move is tied to price move down. Below, we break down what changed for IMVT, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
IMVT fell 6.0% to $41.20
IMVT tumbled 6.0% in its latest session, moving from $43.82 to $41.20.
What it means for Immunovant, Inc. investors
For Immunovant, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Immunovant, Inc. (IMVT) moved +3.34% from $38.96 to $40.26 on 2026-07-17; Immunovant, Inc. (IMVT) moved +2.86% from $38.77 to $39.88 on 2026-07-15. Weighing against that: Material negative event; Sharp 6.0% decline — elevated risk. Wall Street's consensus price target sits at $40.00, implying -2.9% downside from $41.20. BestStocks rates the overall signal quality low (56/100). With earnings roughly 72 days out, the next report is the most likely near-term test of the move.
IMVT price reaction
IMVT last traded at $41.20, down $2.62 (-5.98%) from the previous close of $43.82. The session traded on 0.7× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $38.51 and $44.96, and it currently sits about 42% of the way up that band.
Bullish and bearish analyst opinions on Immunovant, Inc. (IMVT)
The consensus analyst price target on Immunovant, Inc. (IMVT) is $40.00, 2.9% below the recent $41.20. Over the past 90 days analysts logged 0 upgrades, 2 maintains, and 0 downgrades. Here is how the bullish and bearish cases on IMVT line up.
The bullish case
- Immunovant, Inc. (IMVT) moved +3.34% from $38.96 to $40.26 on 2026-07-17.
The bearish case
- The consensus analyst price target of $40.00 sits 2.9% below the recent $41.20, so the average target sees limited room to run.
- The most bearish analyst target is $40.00 (-2.9%).
- Material negative event.
- Sharp 6.0% decline — elevated risk.
- Immunovant, Inc. (IMVT) moved -2.54% from $39.71 to $38.70 on 2026-07-13.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for IMVT
Frequently asked questions about IMVT
Why did Immunovant, Inc. (IMVT) stock move?
IMVT tumbled 6.0% to $41.20. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did IMVT stock fall?
IMVT lost 5.98% ($2.62) versus the prior close of $43.82, last trading at $41.20 on 0.7× average volume.
When is Immunovant, Inc.'s next earnings date?
IMVT's next earnings report is estimated for 2026-11-09 — about 72 days away.
What is the analyst price target for IMVT?
The consensus analyst price target for IMVT is $40.00, about 2.9% below the current $41.20. Over the past 90 days, analysts recorded 0 upgrades, 2 maintains, and 0 downgrades.
How BestStocks tracks IMVT
This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for IMVT, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.